Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-24 @ 11:07 PM
NCT ID:
NCT06116669
Eligibility Criteria:
Inclusion Criteria:
* Willing and able to give informed consent for participation in the trial
* Female aged 18-49 years
* Moderate anemia (Hb \<110 g/L, but not severely anemic with Hb \<80 g/L)
* Iron deficient (ZnPP \>40 mmol/mol haem)
* Anticipated residence in the study area for the study duration
Exclusion Criteria:
* Major chronic infecious disease (e.g., HIV infection);
* Major chronic non-infecious disease (e.g., Type 2 diabetes, cancer);
* Chronic medications;
* Use of iron-containing mineral and vitamin supplementation 2 weeks prior to study start;
* COVID-19 vaccine or confirmed COVID-19 infection within the past 2 years
* MenACWY vaccine in the past
* Typhim Vi vaccine in the past
* Pregnant (confirmed by rapid test during screening)
* Malaria (confirmed by rapid test) à study start will be postponed
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
49 Years
Study:
NCT06116669
Study Brief:
Protocol Section:
NCT06116669